Contact Supplier

Contact Supplier

To get in touch with ARTES Biotechnology GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .

    ARTES presenting at BIO-Europe Stockholm

    news-releasesARTES Biotechnology GmbH
    October 16th 2024

    Langenfeld, Germany: – ARTES Biotechnology, the German-based biopharmaceutical CDMO specializing in development of microbial cell lines for recombinant proteins and vaccines, is returning to participate in Europe’s leading life sciences partnering conference, BIO-Europe 2024, this year in Stockholm for its 30th Anniversary.

    ARTES will have an exhibition booth at the conference (149) at the Stockholmsmässan International Fairs Center, which will display its range of cell lines and process development solutions for biopharma products along with its range of laboratory reagents.

    Innovative vaccine technology

    ARTES will use the numerous networking opportunities at BIO-Europe to attract new interested parties for its service offerings and to present its expertise in microbial cell line and process development. The team will highlight, among other things, the technological advantages of the SplitCore technology, which uses an innovative approach with capsid-like particles (cVLP) for vaccine development, and the patented METAVAX® platform, which was developed for the development of highly immunogenic subunit vaccines.

    About ARTES Biotechnology

    ARTES Biotechnology GmbH is a German company specialized in the development of processes for the production of recombinant proteins from microbial expression systems. In particular, the company offers the development of optimized production cell lines and processes based on yeast (HansenulaPichiaSaccharomyces) and bacteria (E. coli). The expression platforms are complemented by a unique virus-like particle (VLP) technology for antigen presentation and vaccine development. For more than 20 years, ARTES has successfully partnered with human and animal health companies, enzyme manufacturers, and the cosmetics, diagnostics, and nutrition industries. The company operates worldwide from its 945 sqm facility in Langenfeld, Germany.

    More information at http://www.artes-biotechnology.com

    About BIO-Europe 2024

    BIO-Europe® is a premier partnering conference that annually attracts an international “who’s who” of decision-makers from Europe’s biotech, pharma and investment communities for high-caliber networking.

    The three-day 2024 event opens November 4 at the Stockholmsmässan Stockholm International Fairs Center in the Swedish capital, followed by two further days of digital partnering on November 12-13.

    Featuring a sophisticated partnering system, partneringONE®, the event enables delegates to network with companies across the life science value chain, from large biotech and pharma companies to financiers and innovators.

    The 30th Anniversary event is expected to involve up to 5,500 potential partners, representing more than 2,800 companies from around the world, with a conference agenda structured around the headline themes of the Business of Biotech, Therapeutic Insights, and Ecosystem Innovation.

    The program also features more than 20 workshops and panels, with thousands of licensing opportunities posted.

    The event is organized by Informa Connect with more information at: https://informaconnect.com/bioeurope/

    VIDEO PRESENTATION

    ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production.

    FREE DOWNLOAD
    ARTES presenting at BIO-Europe Stockholm

    ARTES Biotechnology GmbH

    Contact Information
    Address: Elisabeth-Selbert-Str. 9, 40764 Langenfeld, Germany
    Telephone No: +49 (0) 2173 27587 0
    Email Address: [email protected]

    Contact ARTES Biotechnology GmbH

    Simply fill out the form below to contact ARTES Biotechnology GmbH now.

    Send ARTES Biotechnology GmbH a Message